Advertisement

Hepatorenal Syndrome

  • Yumi AndoEmail author
  • Joseph Ahn
Chapter

Abstract

This chapter discusses key distinguishing features of hepatorenal syndrome from other etiologies of kidney injury. The pathophysiology as it is currently understood, as well as best treatment options based on clinical evidence, is described. An emphasis is placed on early diagnosis and treatment. Due to the poor prognosis despite maximal medical therapy, referral for liver transplantation should be initiated.

Keywords

Portal hypertension Ascites Terlipressin Norepinephrine Sympathetic nervous system Vasopressin Renin-angiotensin-aldosterone system 

Further Reading

  1. 1.
    AASLD Practice guideline: management of adult patients with ascites due to cirrhosis: Update 2012.Google Scholar
  2. 2.
    Allegretti AS, et al. Prognosis of patients with cirrhosis and AKI who initiate RRT. Clin J Am Soc Nephrol. 2018;13(1):16–25.CrossRefGoogle Scholar
  3. 3.
    Gines A, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. 1993;105(1):229–36.CrossRefGoogle Scholar
  4. 4.
    Gluud L, et al. Terlipressin for hepatorenal syndrome. Cochrane Database Syst Rev. 2012;12(9):CD005162.Google Scholar
  5. 5.
    Israelsen M, et al. Terlipressin vs other vasoactive drugs for hepatorenal syndrome. Cochrane Database Syst Rev Issue. 2017;27(9):CD011532.Google Scholar
  6. 6.
    EASL practice guideline: EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 53:397–417.Google Scholar
  7. 7.
    Modi RM, et al. Outcomes of liver transplantation in patients with hepatorenal syndrome. World J Hepatol. 2016;8(24):999–1011.CrossRefGoogle Scholar
  8. 8.
    Nazar A, et al. Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology. 2010;51(1):219–26.CrossRefGoogle Scholar
  9. 9.
    Salermo F, et al. Diagnosis, prevention, and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56(9):1310–8.Google Scholar
  10. 10.
    Wong F, et al. Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut. 2011;60(5):702–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Medicine, Division of Gastroenterology and HepatologyOregon Health and Science UniversityPortlandUSA

Personalised recommendations